Reduction in voltage-gated K+ channel activity in primary sensory neurons in painful diabetic neuropathy: role of brain-derived neurotrophic factor
about
Diabetic neuropathic pain: Physiopathology and treatmentNeurotrophins and Neuropathic Pain: Role in PathobiologyEpigenetic modification of DRG neuronal gene expression subsequent to nerve injury: etiological contribution to complex regional pain syndromes (Part II)Gastrodin inhibits allodynia and hyperalgesia in painful diabetic neuropathy rats by decreasing excitability of nociceptive primary sensory neurons.Diabetic visceral hypersensitivity is associated with activation of mitogen-activated kinase in rat dorsal root ganglia.Diabetic neuropathy enhances voltage-activated Ca2+ channel activity and its control by M4 muscarinic receptors in primary sensory neurons.Chronic compression of mouse dorsal root ganglion alters voltage-gated sodium and potassium currents in medium-sized dorsal root ganglion neuronsG protein-gated inwardly rectifying potassium channel subunits 1 and 2 are down-regulated in rat dorsal root ganglion neurons and spinal cord after peripheral axotomyNerve injury increases brain-derived neurotrophic factor levels to suppress BK channel activity in primary sensory neurons.Kv3.4 channel function and dysfunction in nociceptors.Topical application of disodium isostearyl 2-O-L-ascorbyl phosphate, an amphiphilic ascorbic acid derivative, reduces neuropathic hyperalgesia in rats.G9a is essential for epigenetic silencing of K(+) channel genes in acute-to-chronic pain transition.Selective inhibition of extracellular signal-regulated kinases 1/2 blocks nerve growth factor to brain-derived neurotrophic factor signaling and suppresses the development of and reverses already established pain behavior in ratsRole of Kv4.3 in Vibration-Induced Muscle Pain in the Rat.Potassium channels in peripheral pain pathways: expression, function and therapeutic potential.Opening paths to novel analgesics: the role of potassium channels in chronic painInhibition of G protein-coupled P2Y2 receptor induced analgesia in a rat model of trigeminal neuropathic pain.BDNF contributes to angiotensin II-mediated reductions in peak voltage-gated K+ current in cultured CATH.a cells.Micronized palmitoylethanolamide reduces the symptoms of neuropathic pain in diabetic patientsBrain-derived neurotrophic factor enhances the excitability of small-diameter trigeminal ganglion neurons projecting to the trigeminal nucleus interpolaris/caudalis transition zone following masseter muscle inflammation.Kv2 dysfunction after peripheral axotomy enhances sensory neuron responsiveness to sustained input.Impairments of the primary afferent nerves in a rat model of diabetic visceral hyposensitivity.Morphological and functional diversity of first-order somatosensory neurons.miR-9 Mediates CALHM1-Activated ATP-P2X7R Signal in Painful Diabetic Neuropathy Rats.Down-regulation of Kv4.3 channels and a-type K+ currents in V2 trigeminal ganglion neurons of rats following oxaliplatin treatment.Central TrkB blockade attenuates ICV angiotensin II-hypertension and sympathetic nerve activity in male Sprague-Dawley rats.A-Type K Channels in Dorsal Root Ganglion Neurons: Diversity, Function, and Dysfunction
P2860
Q27004604-802805B4-4E5F-470D-9435-F04C29D56878Q28084413-5B050F79-D2EC-4EBD-87C9-E239CF25ED85Q33933720-8AFCAF44-A4CE-4D0C-91E9-69DDD66869F8Q34326377-47A5AA3F-6AA8-4AEE-94ED-549F86B2A269Q35043429-F98BAE6C-0894-475C-BA16-A80391BFEA67Q35341725-86EA70A8-7991-4F5F-B38B-C51B04372759Q35811404-0984841E-9CAA-4399-AC99-87A5620628EAQ35879998-BD85D3B2-B9F1-405E-8D4D-46E7134C8C56Q36019756-BCC8ACCB-2C98-4221-B5FA-F1DCD112EEAFQ36124912-0A68F319-13F1-4A1A-913F-414A981EAEE4Q36158968-D7A0B112-4DF0-4EE7-9010-F88CFB29EA5AQ36322506-35E6F504-E00F-4060-A839-01170E941FB6Q36627244-03774C05-4DB3-498A-9BBB-E20AB1737348Q36759147-4DD2D09E-E55C-44EF-AF2D-FE09789B38FAQ37362041-623BBC09-92CE-4E80-8F6D-776FE4C735ABQ37623462-12511BC8-A02F-4980-84CD-53926AFDF7BDQ37715893-4353A98D-4F64-4901-985F-9003C2619D45Q38821987-14C80D61-0074-4CA7-A254-A44832C945FDQ38908402-AA13300F-B59A-4B15-8ECB-847923102773Q41815900-B33354AC-6EF8-432D-B195-9A150C588EEAQ41884563-395735E5-B361-437E-9C25-A2C324C4053CQ46143020-0AA9EB23-4895-44CB-BF1F-4C950AD6D06DQ46709494-99C6F02F-7294-4D75-970F-AB099868E051Q47601918-3A8F7B41-98C0-4248-94B0-FDC9D54A5AD5Q49163692-D06E17B1-E314-4EBF-A74C-294CB7DF47ABQ50976844-F2320529-7255-4810-8F85-C9BEFF0E5CD0Q58799022-DF06817A-4C49-43A3-A2B1-593D123017BE
P2860
Reduction in voltage-gated K+ channel activity in primary sensory neurons in painful diabetic neuropathy: role of brain-derived neurotrophic factor
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Reduction in voltage-gated K+ ...... in-derived neurotrophic factor
@ast
Reduction in voltage-gated K+ ...... in-derived neurotrophic factor
@en
Reduction in voltage-gated K+ ...... in-derived neurotrophic factor
@nl
type
label
Reduction in voltage-gated K+ ...... in-derived neurotrophic factor
@ast
Reduction in voltage-gated K+ ...... in-derived neurotrophic factor
@en
Reduction in voltage-gated K+ ...... in-derived neurotrophic factor
@nl
prefLabel
Reduction in voltage-gated K+ ...... in-derived neurotrophic factor
@ast
Reduction in voltage-gated K+ ...... in-derived neurotrophic factor
@en
Reduction in voltage-gated K+ ...... in-derived neurotrophic factor
@nl
P2093
P2860
P1476
Reduction in voltage-gated K+ ...... in-derived neurotrophic factor
@en
P2093
Hee-Sun Byun
Hui-Lin Pan
Shao-Rui Chen
Xue-Hong Cao
You-Qing Cai
P2860
P304
P356
10.1111/J.1471-4159.2010.06863.X
P407
P577
2010-06-24T00:00:00Z